Location History:
- Gem{hacek over (u)}nden, DE (2011)
- Gumunden, DE (2015)
- Gemunden (Felda), DE (2016)
- Gemünden, DE (2010 - 2017)
- Germünden, DE (2016 - 2017)
- Germunden, DE (2018 - 2020)
- Gemunden, DE (2015 - 2022)
Company Filing History:
7 out of 50 
6 out of 36 
2 out of 44 
Years Active: 2010-2022
Title: Gerd Helftenbein: Innovator in Cancer Diagnosis and Treatment
Introduction:
Gerd Helftenbein, a renowned inventor from Gemunden, Germany, has made significant contributions to the field of cancer diagnosis and treatment. With a remarkable number of 15 patents to his name, Helftenbein has established himself as a leading figure in the innovative research of tumor diseases.
Latest Patents:
Among Helftenbein's recent patents, two stand out for their potential impact on cancer therapy and diagnosis. The first patent encompasses methods and compositions for the diagnosis and treatment of cancer. Helftenbein's invention focuses on the identification of specific nucleic acid and amino acid sequences characteristic of tumor tissues, particularly ovarian and lung tumors. These sequences serve as potential targets for advanced therapeutic interventions and precise diagnoses.
The second patent relates to the identification of the surface-associated antigen FLJ31461 for tumor diagnosis and therapy. Helftenbein's groundbreaking research involves the identification of gene products resulting from tumor-associated expression and their accompanying nucleic acid sequences. This patent offers promising avenues for developing effective therapies and diagnostic tools for diseases associated with aberrant expression of these gene products.
Career Highlights:
Throughout his career, Gerd Helftenbein has made remarkable strides in the quest to combat cancer. He has garnered an impressive portfolio of 15 patents, all of which contribute significantly to the field of cancer research. Helftenbein's dedication to his work has positioned him as an influential authority in the area of tumor diseases.
Collaborations:
Helftenbein has collaborated with prominent companies in the pharmaceutical and biotech sectors. Notably, he has worked with Ganymed Pharmaceuticals Ag and Biontech SE, both leading organizations dedicated to advancing cancer research and therapies. These collaborations have further facilitated Helftenbein's groundbreaking work and allowed for the translation of his innovative ideas into tangible solutions.
Among Helftenbein's notable collaborators are Ugur Sahin and Özlem Türeci. These individuals, renowned figures in their respective fields, have partnered with him to bring about positive changes in cancer diagnosis and therapy. Their collective expertise and shared commitment to innovation have laid the foundation for groundbreaking advancements under Helftenbein's leadership.
Conclusion:
Gerd Helftenbein's dedication to developing novel therapies and diagnostic tools for cancer has been instrumental in advancing the field of oncology. With a remarkable track record of 15 patents, his contributions have the potential to transform the way we diagnose and treat tumor diseases. Helftenbein's collaboration with leading companies and renowned experts underscores the significance of his work and highlights his commitment to innovation. His continued efforts herald a promising future for cancer research, instilling hope for improved patient outcomes and a profound impact on global health.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.